Shocking Storie the Media Buried Today

Cancer Researcher Drops Ivermectin Bombshell

The first peer-reviewed protocol using Ivermectin and Fenbendazole for cancer treatment has finally been peer-reviewed and published.

This is huge. Dr. Makis says he is already seeing “incredible successes with these repurposed drugs.”

Here’s the quick summary of the study’s findings:

• Ivermectin targets cancer cells by disrupting their mitochondrial function, leading to cell death (apoptosis). It also blocks key energy pathways, showing significant tumor shrinkage, especially in pancreatic cancer.

• Fenbendazole and Mebendazole, both antiparasitic drugs, have been found to halt cancer cell growth, interfere with glucose metabolism, and trigger apoptosis. In some preclinical trials, these drugs have even outperformed standard chemotherapy in reducing tumor growth.

• Remarkably, three patients with stage IV genitourinary cancers were treated with high-dose Fenbendazole (1,000 mg, three times a week for several months) and experienced complete remission.

This is remarkable and especially hopeful for patients who have tried everything else with no luck. The next step will be further clinical trials to validate the protocol's effectiveness among larger populations.

Subscribe @imPascalNajadi

@EBSstory